Home Health Monitoring Market Size: Global Overview

The global home health monitoring market size was valued at USD 390.24 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.96% from 2024 to 2030. This can be attributed to the rising demand for cost-effective alternatives to curb rising healthcare costs and the growing penetration of virtual and remote care.

The global patient monitoring devices market size was valued at USD 51.1 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.7% from 2023 to 2030. The expansion of the industry can be attributed to the rise in demand for monitoring devices used to measure, distribute, record, and display a variety of biometric data, including blood pressure, temperature, and blood oxygen saturation level.

The global digital patient monitoring devices market size was estimated at USD 178.06 billion in 2024 and is projected to grow at a CAGR of 25.2% from 2025 to 2030. The rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, and hypertension, and the increasing geriatric population are the factors that are anticipated to have an impact on the market growth.

The global remote patient monitoring system market size was estimated at USD 5.2 billion in 2023 and is expected to register a compound annual growth rate (CAGR) of 18.6% from 2024 to 2030. The outbreak of COVID-19 caused a significant impact on the remote patient monitoring system. The remote monitoring systems serve with improved chronic disease management including early warning signs and progress tracker thus boosting its demand in the coming years at a global level.

The global market size and growth rate

The global market size for home health monitoring was valued at USD 390.24 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.96% from 2024 to 2030. The market is expected to reach USD 666.9 billion by 2030. The rising demand for cost-effective alternatives to curb rising healthcare costs and the growing penetration of virtual and remote care industries are the key factors driving the market's growth.

The COVID-19 pandemic has positively impacted the market for patient monitoring devices. The pandemic has raised the demand for patient monitoring in regions such as Asia and the Middle East and Africa due to hospital visit restrictions. During the pandemic, governments made attempts to monitor the health of patients, contributing to the expansion of the market.

The market for patient monitoring devices was valued at USD 51.1 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.7% from 2023 to 2030. The expansion of the industry can be attributed to the rise in demand for monitoring devices used to measure, distribute, record, and display a variety of biometric data, including blood pressure, temperature, and blood oxygen saturation level.

The global remote patient monitoring system market size was estimated at USD 5.2 billion in 2023 and is expected to register a compound annual growth rate (CAGR) of 18.6% from 2024 to 2030. The outbreak of COVID-19 caused a significant impact on the remote patient monitoring system. The remote monitoring systems serve with improved chronic disease management including early warning signs and progress tracker thus boosting its demand in the coming years at a global level.

The global digital patient monitoring devices market size was estimated at USD 178.06 billion in 2024 and is projected to grow at a CAGR of 25.2% from 2025 to 2030. The rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, and hypertension and the increasing geriatric population are the factors that are anticipated to have an impact on the market growth.

Market trends and factors

• The rise of remote patient monitoring (RPM) and the shift from hospital care to home care settings: The COVID-19 pandemic accelerated the adoption of RPM, allowing companies to demonstrate the convenience, cost-effectiveness, and effectiveness of their devices. RPM enables healthcare providers to monitor patients' health remotely and has been increasingly adopted in recent years.
• The increasing prevalence of chronic diseases: Chronic diseases, such as cardiovascular diseases, COPD, cancer, and type II diabetes, are on the rise globally and are expected to boost the demand for patient monitoring devices. According to the WHO, chronic diseases accounted for around 73% of all deaths and 60% of the global disease burden in 2020.
• Technological advancements: The need for advanced and accurate monitoring systems is increasing as healthcare organizations strive to provide better services. Patient monitoring is evolving from ad-hoc to continuous monitoring to provide accurate data to clinicians for treatment decisions. Technological advancements, such as silicon solutions and single-chip devices that combine multiple parameters into a low-cost, low-power integrated solution, support this shift.
• The expansion of the industry into developing economies: Developing economies, particularly the Asia-Pacific region, present significant growth opportunities due to their large geriatric populations, the rising prevalence of chronic diseases, and the increasing adoption of remote patient monitoring. China and India, for example, have the largest diabetic populations globally, and this number is projected to rise.
• The impact of the COVID-19 pandemic: The pandemic increased the demand for patient monitoring devices, particularly respiratory monitoring devices, and accelerated the shift towards patient monitoring devices and remote care. It also highlighted the importance of remote patient monitoring in managing and containing infectious diseases.
• The integration of artificial intelligence (AI): AI-powered patient monitoring devices and systems enable real-time data analysis, predictive risk stratification, and the development of personalized treatment plans, improving patient outcomes. AI can analyze large datasets from patient monitoring in real time, identifying critical trends and potential issues as they occur.
• The role of government regulations and reimbursement policies: Government regulations and reimbursement policies can either facilitate or hinder market growth, depending on the region. For example, favorable reimbursement policies in the U.S. and Europe support the adoption of remote patient monitoring, while stringent regulatory policies and reimbursement cuts may hinder market growth.

Market segmentation by product type

The market for home health monitoring devices can be segmented by product type into several categories, including:

• Blood glucose monitoring systems: These devices allow patients to monitor their blood sugar levels and help manage conditions such as diabetes. This segment can be further divided into self-monitoring, continuous glucose monitoring, and wearable glucose monitoring systems.
• Cardiac monitoring devices: These devices are used to monitor heart function and include products such as implantable loop recorders, mobile cardiac telemetry monitors, and smart/wearable ECG monitors.
• Multi-parameter monitoring devices: These devices simultaneously measure multiple physiological parameters, such as blood pressure, heart rate, and body temperature. They can be further categorized into low-acuity, mid-acuity, and high-acuity monitoring devices.
• Respiratory monitoring devices: These devices monitor respiratory function and include products such as pulse oximeters, spirometers, capnographs, and peak flow meters.
• Hemodynamic/pressure monitoring devices: This category includes devices that monitor blood flow, blood pressure, and cardiac function. Examples include hemodynamic monitors and blood pressure monitors.
• Weight monitoring devices: These devices help track a patient's weight and body composition and can be divided into digital and analog weight monitoring devices.
• Fetal and neonatal monitoring devices: These devices are used to monitor the health of unborn babies and newborns and may include fetal monitors and neonatal monitoring devices.
• Neuromonitoring devices: These devices are used to monitor brain function and include electroencephalograph machines, electromyography machines, intracranial pressure monitors, magnetoencephalograph machines, and transcranial Doppler machines.
• Temperature monitoring devices: These devices measure body temperature and can be categorized into handheld, table-top, wearable continuous, invasive, and smart temperature monitoring devices.
• Other patient monitoring devices: This category includes a range of devices such as polysomnography devices, wearable sleep monitoring devices, urine output monitoring devices, and apnea and sleep monitors.

Market segmentation by end-use

The home health monitoring market is segmented by end-use into hospitals, ambulatory surgical centres, home care settings, and other end users.

Hospitals

The hospital segment dominated the patient monitoring devices market and accounted for the largest revenue share of more than 51.1% in 2022. The significant revenue share of the segment is attributed to the increasing importance of accurate and timely disease detection in hospitals, as well as the rising volume of procedures performed there.

The expansion of the segment is fuelled by an increase in the number of patients being admitted to hospitals owing to injuries, chronic diseases, and other situations. In general wards and intensive care units, multiparameter patient monitors are frequently used to continually track patients' health using different human vital parameters, such as oxygen saturation, respiration rate, blood pressure, and heart rate.

Ambulatory Surgical Centres

The home care segment is anticipated to witness rapid growth over the forecast period. The development of next-generation therapeutic, display, diagnostic, and monitoring devices, which are more adaptable, precise, and small, is accelerating due to the trend toward portability and the delivery of treatment at home or at the bedside.

Home Care Settings

The services segment dominated the market and held the largest revenue share of 84.21% in 2023. The market by services is segmented into skilled home healthcare and unskilled home healthcare. Skilled services are provided by healthcare professionals. Unskilled services include non-medical home care services provided for daily living aid to home-bound patients and are categorized as basic assistance care/personal care service. Rising medical expenditure associated with hospital stays is expected to boost the demand for skilled care.

Under skilled nursing services, medical professionals such as physicians, registered nurses, physiotherapists, and specialty care providers aid patients at home or in home care centres. The aging population suffering from diseases, such as diabetes and cardiac disorders, require medical assistance services such as medication management and continuous monitoring. With advancements in medical technology, many procedures can be performed at home in a more comfortable and convenient environment, which can be attributed to the growth of skilled home care services in the market for home healthcare.

Other End Users

The equipment is segmented as therapeutic, diagnostic, and mobility assistance. Diagnostics accounted for the largest share in 2023 and is expected to gain a lucrative share over the forecast period. Technologically advanced products that enable accurate and timely diagnosis, such as remote heart rate monitors, iPhone heart-rate monitors, and TQR heart rate watches, are likely to propel the diagnostic equipment segment's growth.

Market segmentation by region

North America

The North American market is expected to dominate the global home health monitoring market during the forecast period. The region's market growth is driven by the presence of a large number of major market players, the high adoption rate of advanced technologies, and the increasing prevalence of chronic diseases. In addition, the region's well-developed healthcare infrastructure and relatively high disposable income are expected to drive the market growth. The North American market is further segmented into the US and Canada, with the US dominating the regional market. The US market is driven by the presence of a large number of major market players, the high adoption rate of advanced technologies, and the increasing prevalence of chronic diseases.

Europe

The European market is expected to be the second-largest regional market during the forecast period. The region's market growth is driven by the presence of a large number of major market players, the high adoption rate of advanced technologies, and the increasing prevalence of chronic diseases. The European market is further segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe, with Germany dominating the regional market. The German market is driven by the presence of a large number of major market players, the high adoption rate of advanced technologies, and the increasing prevalence of chronic diseases.

Asia Pacific

The Asia Pacific market is expected to be the fastest-growing regional market during the forecast period. The region's market growth is driven by the presence of a large number of major market players, the high adoption rate of advanced technologies, and the increasing prevalence of chronic diseases. The Asia Pacific market is further segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific, with China dominating the regional market. The Chinese market is driven by the presence of a large number of major market players, the high adoption rate of advanced technologies, and the increasing prevalence of chronic diseases.

Latin America

The Latin American market is expected to be the second-fastest-growing regional market during the forecast period. The region's market growth is driven by the presence of a large number of major market players, the high adoption rate of advanced technologies, and the increasing prevalence of chronic diseases. The Latin American market is further segmented into Brazil, Mexico, and the Rest of Latin America, with Brazil dominating the regional market. The Brazilian market is driven by the presence of a large number of major market players, the high adoption rate of advanced technologies, and the increasing prevalence of chronic diseases.

Middle East and Africa

The Middle East and African market is expected to be the slowest-growing regional market during the forecast period. The region's market growth is driven by the presence of a large number of major market players, the high adoption rate of advanced technologies, and the increasing prevalence of chronic diseases. The Middle East and African market is further segmented into South Africa, Saudi Arabia, the United Arab Emirates, and the Rest of the Middle East and Africa, with South Africa dominating the regional market. The South African market is driven by the presence of a large number of major market players, the high adoption rate of advanced technologies, and the increasing prevalence of chronic diseases.

Frequently asked questions